Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
Jason D. Merker(Dana-Farber Brigham Cancer Center), Nicholas C. Turner(Institute of Cancer Research), Patricia A. Hurley(Dana-Farber Brigham Cancer Center), Brooke L. Billman(Dana-Farber Brigham Cancer Center), Suanna S. Bruinooge(Dana-Farber Brigham Cancer Center), Richard L. Schilsky(American Society of Clinical Oncology), Christina M. Lockwood(Dana-Farber Brigham Cancer Center), Apostolia M. Tsimberidou(The University of Texas MD Anderson Cancer Center), Geoffrey R. Oxnard(Foundation Medicine (United States)), Alexander J. Lazar(The University of Texas MD Anderson Cancer Center), Patricia Vasalos(Dana-Farber Brigham Cancer Center), Daniel F. Hayes(University of Michigan–Ann Arbor), Thomas K. Oliver(Dana-Farber Brigham Cancer Center), Maximilian Diehn(Stanford University), Neal Lindeman(Dana-Farber Brigham Cancer Center), Carolyn C. Compton(University of Arizona)
Cited by 925
Related Papers
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer
|New England Journal of Medicine|2015|1.6k
Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M
|Nature Medicine|2015|1.5k
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k